From receptor balance to rational glucocorticoid therapy

Endocrinology

Volumn 155, Issue 8, 2014, Pages 2754-2769

  De Kloet, E Ron ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BRAIN; CIRCADIAN RHYTHM; ENDOCRINOLOGY; FEEDBACK, PHYSIOLOGICAL; HISTORY, 20TH CENTURY; HUMANS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84905001682     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1048     Document Type: Review

References (200)

1. McEwen BS, Weiss JM, Schwartz LS. Selective retention of corti-costerone by limbic structures in rat brain. Nature. 1968; 220:911-912.
2. De Kloet R, Wallach G, McEwen BS. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology. 1975; 96:598-609.
3. McEwen BS, de Kloet R, Wallach G. Interactions in vivo and in vitro of corticoids and progesterone with cell nuclei and soluble macromolecules from rat brain regions and pituitary. Brain Res. 1976; 105:129-136.
4. De Kloet ER, Reul JM. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology. 1987; 12:83-105.
5. De Kloet ER. Brain corticosteroid receptor balance and homeo-static control. Front Neuroendocrinol. 1991; 12:95-164.
6. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. Brain corticoste-roid receptor balance in health and disease. Endocr Rev. 1998; 19: 269-301.
7. De Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nature Rev Neurosci. 2005; 6:463-475.
8. Hermans EJ, Henckens M, Joëls M, Fernandez G. Dynamic adaptation of large-scale brain networks in response to acute stressors. Trends Neurosci. 2014; 37:304-314.
9. Dallman MF, Yates FE. Dynamic asymmetries in the cortico-steroid feedback path and distribution-metabolism-binding elements of the adrenocortical system. Ann NY Acad Sci. 1969; 156:696-721.
10. Dallman MF, Akana SF, Cascio CS, Darlington D.N., Jacobson L., Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res. 1987; 43:113-173.
11. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000; 21:55-89.
12. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984; 5:25-44.
13. de Kloet ER, van der Vies J, de Wied D. The site of the suppressive action of dexamethasone on pituitary-adrenal activity. Endocrinology. 1974; 94:61-73.
14. Rotsztejn WH, Normand M, Lalonde J, Fortier C. Relationship between ACTH release and corticosterone binding by the receptor sites of the adenohypophysis and dorsal hippocampus following infusion of corticosterone at a constant rate in the adrenalecto-mized rat. Endocrinology. 1975; 97:223-230.
15. Beaumont K, Fanestil DD. Characterization of rat brain aldoste-rone receptors reveals high affinity for corticosterone. Endocrinology. 1983; 113:2043-2051.
16. Krozowski ZS, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA. 1983; 80:6056-6060.
17. Moguilewsky M, Raynaud JP. Evidence for a specific mineralo-corticoid receptor in rat pituitary and brain. J Steroid Biochem. 1980; 12:309-314.
18. Gomez-Sanchez CE, Gomez-Sanchez EP. RU-26988-a new tool for the study of the mineralocorticoid receptor. Endocrinology. 1983; 113:1004-1009.
19. Coirini H, Magariños AM, De Nicola AF, Rainbow TC, McEwen BS. Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro. Brain Res. 1985; 361:212-216.
20. Veldhuis HD, Van Koppen C, Van Ittersum M, De Kloet ER. Specificity of the adrenal steroid receptor system in rat hippocampus. Endocrinology. 1982; 110:2044-2051.
21. Veldhuis HD, De Kloet ER. Antagonistic effects of aldosterone on corticosteroid-mediated changes in exploratory behavior of adrenalectomized rats. Horm Behav. 1983; 17:225-232.
22. Fuxe K, Wikström AC, Okret S, et al. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology. 1985; 117:1803-1812.
23. Reul JM, de Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985; 117:2505-2511.
24. Arriza JL, Weinberger C, Cerelli G, et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 1987; 237: 268-275.
25. Arriza JL, Simerly RB, Swanson LW. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron. 1988; 1:887-900.
26. Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol. 2013; 132:1033-1044.
27. Nishi M, Kawata M. Dynamics of glucocorticoid receptor and mineralocorticoid receptor: implications from live cell imaging studies. Neuroendocrinology. 2007; 85:186-192.
28. van Steensel B, Brink M, van der Meulen K, et al. Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus. J Cell Sci. 1995; 108:3003-3011.
29. Polman JA, de Kloet ER, Datson NA. Two populations of glucocorticoid receptor-binding sites in the male rat hippocampal genome. Endocrinology. 2013; 154:1832-1844.
30. Datson NA, van der Perk J, de Kloet ER, Vreugdenhil E. Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur J Neurosci. 2001; 14:675-689.
31. Datson NA, van den Oever JM, Korobko OB, Magarinos AM, de Kloet ER, McEwen BS. Previous history of chronic stress changes the transcriptional response to glucocorticoid challenge in the dentate gyrus region of the male rat hippocampus. Endocrinology. 2013; 154:3261-3272.
32. Edwards CRW, Stewart PM, Burt D, et al. Localisation of 11/3-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. 1988; 2(8618):986-989.
33. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988; 242:583-585.
34. Quinkler M, Stewart PM. Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab. 2003; 88:2384-2392.
35. Funder J, Myles K. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. Endocrinology. 1996; 137:5264-5268.
36. Yau JL, Noble J, Seckl JR. 11 /3-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid receptor to mineralocorticoid receptor-mediated cognitive control. J Neurosci. 2011; 16:4188-4193.
37. Wyrwoll CS, Holmes MC, Seckl JR. 11/3-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol. 2011; 32:265-286.
38. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest. 1995; 96:1698-1705.
39. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER. Penetration of dexamethasone in brain glucocorticoid targets is enhanced in mdr1a P-glycoprotein knockout mice. Endocrinology. 1998; 139:1789-1793.
40. Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry. 1976; 33:1051-1058.
41. Heuser I, Yassouridis A, Holsboer F. The combined dexametha-sone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res. 1994; 28:341-356.
42. Shorter E, Fink M. Endocrine Psychiatry: Solving the Riddle of Melancholia. New York, NY: Oxford University Press; 2010.
43. Ahima R, Krozowski Z, Harlan R. Type I corticosteroid receptorlike immunoreactivity in the rat CNS: distribution and regulation by corticosteroids. J Comp Neurol. 1991; 313:522-538.
44. Ahima RS, Harlan RE. Charting of type II glucocorticoid receptorlike immunoreactivity in the rat central nervous system. NeuroScience. 1990; 39:579-604.
45. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009; 10:397-409.
46. Geerling JC, Loewy AD. Aldosterone in the brain. Am J Physiol Renal Physiol. 2009; 297:F559-F576.
47. Gomez-Sanchez EP. Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule? Trends Endocrinol Metab. 2011; 22:179-187.
48. Krause EG, de Kloet AD, Flak JN, et al. Hydration state controls stress responsiveness and social behavior. J Neurosci. 2011; 31: 5470-5476.
49. Holaday JW, Martinez HM, Natelson BH. Synchronizedultradian cortisol rhythms in monkeys: persistence during corticotropin infusion. Science. 1977; 198:56-58.
50. Lightman SL, Conway-Campbell BL. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nature Rev Neurosci. 2010; 11:710-718.
51. Walker JJ, Spiga F, Waite E, et al. The origin of glucocorticoid hormone oscillations. PLoS Biol. 2012; 10(6):e1001341.
52. Qian X, Droste SK, Lightman SL, Reul J.M., Linthorst A. Circadian and ultradian rhythms of free glucocorticoid hormone are highly synchronized between the blood, the subcutaneous tissue and the brain. Endocrinology. 2012; 153:4346-4353.
53. Sarabdjitsingh RA, Conway-Campbell BL, Leggett JD, et al. Stress responsiveness varies over the ultradian glucocorticoid cycle in a brain-region-specific manner. Endocrinology. 2010; 151:5369-5379.
54. Sarabdjitsingh RA, Isenia S, Polman A, et al. Disrupted corticosterone pulsatile patterns attenuate responsiveness to glucocorticoid signaling in rat brain. Endocrinology. 2010; 151:1177-1186.
55. Bradbury MJ, Akana SF, Dallman MF. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation. Endocrinology. 1994; 134:1286-1296.
56. Ratka A, Sutanto W, Bloemers M, de Kloet ER. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology. 1989; 50:117-123.
57. Conway-Campbell BL, Pooley JR, Hager GL, Lightman SL. Molecular dynamics of ultradian glucocorticoid receptor action. Mol Cell Endocrinol. 2012; 348:383-393.
58. van Haarst AD, Oitzl MS, Workel JO, de Kloet ER. Chronic brain glucocorticoid receptor blockade enhances the riseincircadian and stress-induced pituitary-adrenal activity. Endocrinology. 1996; 137:4935-4943.
59. Raff H. Teaching glucocorticoid negative feedback and adreno-cortical regulation using a classic paper by dr Dwight Ingle. Advan Physiol Edu. 2005; 29:141-143.
60. Schmidt MV, Sterlemann V, Wagner K, et al. Postnatal glucocor-ticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences. Endocrinology. 2009; 150:2709-2716.
61. de Kloet ER, Burbach P, Mulder GH. Localization and role of transcortin-like molecules in the anterior pituitary. Mol Cell Endocrinol. 1977; 7:261-273.
62. Koch B, Lutz-Bucher B, Briaud B., Mialhe C. Specific interaction of corticosteroids with binding sites in the plasma membranes of the rat anterior pituitary gland. J Endocrinol. 1978; 79:215-222.
63. Qian X, Droste SK, Gutièrrez-Mecinas M, et al. A rapid release of corticosteroid-binding globulin from the liver restrains the gluco-corticoid hormone response to acute stress. Endocrinology. 2011; 152:3738-3748.
64. Russell GM, Henley DE, Leendertz, et al. Rapid glucocorticoid receptor-mediated inhibition of hypothalamo-pituitary-adrenal ultradian activity in healthy males. J Neurosci. 2010; 30:6106-6115.
65. Laryea G, Schütz G, Muglia LJ. Disrupting hypothalamic gluco-corticoid receptors causes HPA axis hyperactivity and excess adiposity. Mol Endocrinol. 2013; 27:1655-1665.
66. Evans AN, Liu Y, Macgregor R, Huang V., Aguilera G. Regulation of hypothalamic corticotropin-releasing hormone transcription by elevated glucocorticoids. Mol Endocrinol. 2013; 27:1796-1807.
67. Sharma D, Bhave S, Gregg E, Uht R. Dexamethasone induces a putative repressor complex and chromatin modifications in the CRH promoter. Mol Endocrinol. 2013; 27:1142-1152.
68. Elliott E, Ezra-Nevo G, Regev L, Neufeld-Cohen A, Chen A. Resilience to social stress coincides with functional DNA meth-ylation of the Crf gene in adult mice. Nat Neurosci. 2010; 13: 1351-1353.
69. Dallman MF, Akana SF, Scribner KA, et al. Mortyn Jones Memorial Lecture. Stress, feedback and facilitation in the hypothalamo-pituitaty-adrenal axis. J Neuroendocrinol. 1992; 4:517-526.
70. Dallman MF. Fast glucocorticoid actions on brain: back to the future. Front Neuroendocrinol. 2005; 26:103-108.
71. Herman JP, Figueiredo H, Mueller NK, et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypo-thalamo-pituitary- adrenocortical responsiveness. Front Neuroendocrinol. 2003; 24:151-180.
72. Evanson NK, Tasker JG, Hill MN, Hillard C.J., Herman JP. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology. 2010; 151:4811-4819.
73. Andrews MH, Wood SA, Windle RJ, Lightman S.L., Ingram CD. Acute glucocorticoid administration rapidly suppresses basal and stress-induced hypothalamo-pituitary-adrenal axis activity. Endocrinology. 2012; 153:200-211.
74. Gutièrrez-Mecinas M., Trollope AF, Collins A, et al. Long-lasting behavioral responses to stress involve a direct interaction of glu-cocorticoid receptors with ERK1/2-MSK1-Elk-1 signaling. Proc Natl Acad Sci USA. 2011; 108:13806-13811.
75. Hunter RG, Murakami G, Dewell S, et al. Acute stress and hip-pocampal histone H3 lysine 9 trimethylation, a retrotransposon silencing response. Proc Natl Acad Sci USA. 2012; 109:17657-17662.
76. Hunter RG, McEwen BS. Stress and anxiety across the lifespan: structural plasticity and epigenetic regulation. Epigenomics. 2013; 5:177-194.
77. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000; 23:477-501.
78. Myers B, McKlveen JM, Herman JP. Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress. Front Neuroendocrinol. 2014; 35:180-196.
79. Joëls M, de Kloet ER. Control of neuronal excitability by cortico-steroid hormones. Trends Neurosci. 1992; 15:25-30.
80. Joëls M, Baram TZ. The neuro-symphony of stress. Nat Rev Neu-rosci. 2009; 10:459-466.
81. Joëls M, Sarabdjitsingh RA, Karst H. Unraveling the time domains of corticosteroid hormone influences onbrain activity: rapid, slow, and chronic modes. Pharmacol Rev. 2012; 64:901-938.
82. Karst H, Berger S, Turiault M, Tronche F., Schütz G, Joëls M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticoste-rone. Proc Natl Acad Sci USA. 2005; 102:19204-19207.
83. Karst H, Berger S, Erdmann G, Schütz G, Joëls M. Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci USA. 2010; 107:14449-14454.
84. Olijslagers JE, de Kloet ER, Elgersma Y, van Woerden GM, Joëls M, Karst H. Rapid changes in hippocampal CA1 pyramidal cell function via pre-as well as postsynaptic membrane mineralocor-ticoid receptors. Eur J Neurosci. 2008; 27:2542-2450.
85. Yuen EY, Liu W, Karatsoreos IN, et al. Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory. Mol Psychiatry. 2011; 16:156-170.
86. Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glu-cocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci. 2003; 23:4850-4857.
87. Joëls M, de Kloet ER. Effects of glucocorticoids and norepineph-rine on the excitability in the hippocampus. Science. 1989; 245: 1502-1505.
88. Joëls M, de Kloet ER. Mineralocorticoid receptor-mediated changes in membrane properties of rat CA1 pyramidal neurons in vitro. Proc Natl Acad Sci USA. 1990; 87:4495-4498.
89. Diamond DM, Bennett MC, Fleshner M, Rose GM. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus. 1992; 2:421-430.
90. Diamond DM, Campbell AM, Park CR, Halonen J, Zoladz PR. The temporal dynamics model of emotional memory processing: a synthesis on the neurobiological basis of stress-induced amnesia, flashbulb and traumatic memories, and the Yerkes-Dodson law. Neural Plast. 2007; 60803.
91. Krugers HJ, Hoogenraad CC, Groc L. Stresshormones and AMPA receptor trafficking in synaptic plasticity and memory. Nat Rev Neurosci. 2010; 11:675-681.
92. Sandi C. Glucocorticoids act on glutamatergic pathways to affect memory processes. Trends Neurosci. 2011; 34:165-176.
93. Oitzl MS, de Kloet ER. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neu-rosci. 1992; 106:62-71.
94. Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdala. Nature Rev Neurosci. 2009; 10:423-433.
95. Revest JM, Le Roux A, Roullot-Lacarrière V, et al. BDNF-TrkB signaling through Erk1/2MAPK phosphorylation mediates the enhancement of fear memory induced by glucocorticoids [published online October 15, 2013]. Mol Psychiatry. doi:101038/ mp.2013134.
96. Joëls M. Corticosteroid effects in the brain: u-shape it. Trends Pharmacol Sci. 2006; 27:244-250.
97. Morsink MC, Steenbergen PJ, Vos JB, et al. Acute activation of hippocampal glucocorticoid receptors results in different waves of gene expression throughout time. J Neuroendocrinol. 2006; 18: 239-252.
98. Qi XR, Kamphuis W, Wang S, et al. Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendo-crinology. 2013; 38:863-870.
99. Klok MD, Alt SR, Lafitte IAJ, et al. Decreased expression of min-eralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J Psychiatry Res. 2011; 45:871-878.
100. Wang SS, Kamphuis W, Huitinga I, Zhou J.N., Swaab DF. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry. 2008; 13:786-799, 741.
101. Boyle MP, Kolber BJ, Vogt S.K., Wozniak DF, Muglia LJ. Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness. J Neurosci. 2006; 26:1971-1978.
102. Arnett MG, Kolber BJ, Boyle MP, Muglia LJ. Behavioral insights from mouse models of forebrain-and amygdala-specific glucocor-ticoid receptor genetic disruption. Mol Cell Endocrinol. 2011; 336: 2-5.
103. Fitzsimons CP, vanHooijdonk LW, Schouten M, et al. Knockdown of the glucocorticoid receptor alters functional integration of newborn neurons in the adult hippocampus and impairs fear-motivated behavior. Mol Psychiatry. 2013; 18:993-1005.
104. Harris AP, Holmes MC, de Kloet ER, Chapman KE, Seckl JR. Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour. Psychoneuroendocrinology. 2013; 38: 648-658.
105. DeRijk RH, de Kloet ER, Zitman FG, van Leeuwen N. Mineralo-corticoid receptor gene variants as determinants of HPA axis regulation and behavior. Endocr Dev. 2011; 20:137-148.
106. Spijker AT, van Rossum EF. Glucocorticoid sensitivity in mood disorders. Neuroendocrinology. 2012; 95:179-186.
107. Quax RA, Manenschijn L, Koper JW, et al. Glucocorticoid sensitivity in health and disease. Nat Rev Endocrinol. 2013; 9:670-686.
108. Binder EB. The role of FKBP5, a co-chaperone of the glucocor-ticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology. 2009; 34:S186-S195.
109. Szyf M, Weaver IC, Champagne FA, Diorio J, Meaney MJ. Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Front Neuroendocrinol. 2005; 26:139-162.
110. Heim C, Binder EB. Current research trends in early life stress and depression: review of human studies on sensitive periods, geneenvironment interactions, and epigenetics. Exp Neurol. 2012; 233: 102-111.
111. Crudo A, Petropoulos S, Suderman M, et al. Effects of antenatal synthetic glucocorticoid on glucocorticoid receptor binding, DNA methylation, and genome-wide mRNA levels in the fetal male hippocampus. Endocrinology. 2013; 154:4170-4181.
112. Oitzl MS, Champagne DL, van der Veen R, de Kloet ER. Brain development under stress: hypotheses of glucocorticoid action revisited Neurosci Biobeh Rev. 2010; 34:584-591.
113. Herman JP. Neural control of chronic stress adaptation. Front Behav Neurosci. 2013; 7:61.
114. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986; 7:284-301.
115. Schoenfeld TJ, Gould E. Stress, stress hormones, and adult neurogenesis. Exp Neurol. 2012; 233:12-21.
116. McEwen BS. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism. 2005; 54:20-23.
117. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007; 87:873-904.
118. McEwen BS, Morrison JH. The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron. 2013; 79:16-29.
119. Feldker DE, Morsink MC, Veenema AH, et al. The effect of chronic exposure to highly aggressive mice on hippocampal gene expression of non-aggressive subordinates. Brain Res. 2006; 1089:10-20.
120. Gray JD, Rubin TG, Hunter RG, McEwen BS. Hippocampal gene expression changes underlying stress sensitization and recovery [published online December 17, 2013]. Mol Psychiatry. doi: 101038/mp.2013175.
121. van Gemert NG, Joëls M. Effect of chronic stress and mifepristone treatment on voltage-dependent Ca2 + currents in rat hippocampal dentate gyrus. J Neuroendocrinol. 2006; 18:732-741.
122. Polman JA, Hunter RG, Speksnijder N, et al. Glucocorticoids modulate the mTOR pathway in the hippocampus: differential effects depending on stress history. Endocrinology. 2012; 153:4317-4327.
123. Jernigan CS, Goswami DB, Austin MC, et al. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 35:1774-1779.
124. Ferguson D, Sapolsky R. Overexpression of mineralocorticoid and transdominant glucocorticoid receptor blocks the impairing effects of glucocorticoids on memory. Hippocampus. 2008; 18:1103-1111.
125. Mitra R, Ferguson D, Sapolsky RM. Mineralocorticoid receptor overexpression in basolateral amygdala reduces corticosterone secretion and anxiety. Biol Psychiatry. 2009; 66:686-690.
126. Dumas TC, Gillette T, Ferguson D, Hamilton K., Sapolsky RM. Anti-glucocorticoid gene therapy reverses the impairing effects of elevated corticosterone on spatial memory, hippocampal neuronal excitability, and synaptic plasticity. J Neurosci. 2010; 30:1712-1720.
127. Oitzl MS, Fluttert M, Sutanto W, de Kloet ER. Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats. Eur J Neurosci. 1998; 10:3759-3766.
128. Oomen CA, Mayer JL, de Kloet ER, Joëls M, Lucassen PJ. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress. Eur J Neurosci. 2007; 26:3395-3401.
129. Datson NA, Speksnijder N, Mayer JL, et al. The transcriptional response to chronic stress and glucocorticoid receptor blockade in the hippocampal dentate gyrus. Hippocampus. 2012; 22:359-371.
130. Barik J, Marti F, Morel C, et al. Chronic stress triggers social aversion via glucocorticoid receptor in dopaminoceptive neurons. Science. 2013; 339:332-335.
131. Niwa M, Jaaro-Peled H, Tankou S, et al. Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science. 2013; 339:335-339.
132. Kruk MR, Halász J, Meelis W, Haller J. Fast positive feedback between the adrenocortical stress response and a brain mechanism involved in aggressive behavior. Behav Neurosci. 2004; 118:1062-1070.
133. Kruk MR, Haller J, Meelis W, de Kloet ER. Mineralocorticoid receptor blockade during a rat's first violent encounter inhibits its subsequent propensity for violence. Behav Neurosci. 2013; 127: 505-514.
134. Ter Horst JP, van der Mark M, Kentrop J, et al. Deletion of the forebrain mineralocorticoid receptor impairs social discrimination and decision-making in male, but not in female mice. Front Behav NeuroScience. 2014; 8:26.
135. Schwabe L, Tegenthoff M, Höffken O, Wolf OT. Mineralocorticoid receptor blockade prevents stress-induced modulation of multiple memory systems in the human brain. Biol Psychiatry. 2013; 74:801-808.
136. Cornelisse S, Joëls M, Smeets T. A randomized trial on mineralo-corticoid receptor blockade in men: effects on stress responses, selective attention, and memory. Neuropsychopharmacology. 2011; 36:2720-2728.
137. Dias-Ferreira E, Sousa JC, Melo I, et al. Chronic stress causes frontostriatal reorganization and affects decision making. Science. 2009; 325:621-625.
138. Schwabe L, Schächinger H, deKloet E.R., Oitzl MS. Corticosteroids operate as a switch between memory systems. J Cogn Neurosci. 2010; 22:1362-1372.
139. Oitzl MS, Schwabe L, Aggleton JP. Memory formation: its changing face. Neurosci Biobehav Rev. 2012; 36:1577-1578.
140. ter Horst JP, Kentrop J, de Kloet ER, Oitzl MS. Stress and estrous cycle affect strategy but not performance of female C57BL/6J mice. Behav Brain Res. 2013; 241:92-95.
141. Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neu-ropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 2012; 169:491-497.
142. Tiemensma J, Kaptein AA, Pereira A.M., Smit JW, Romijn JA, Biermasz NR. Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas. J Clin Endocrinol Metab. 2011; 96:964-971.
143. Lachize S, Apostolakis EM, van der Laan S, et al. Steroid receptor coactivator-1 is necessary for regulation of corticotropin-releasing hormone by chronic stress and glucocorticoids. Proc Natl Acad Sci USA. 2009; 106:8038-8042.
144. Zalachoras I, Houtman R, Atucha E, et al. Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator. Proc Natl Acad Sci USA. 2013; 110:7910-7915.
145. Romijn JA, Smit JW, Lamberts SW. Intrinsic imperfections of endocrine replacement therapy. Eur J Endocrinol. 2003; 149:91-97.
146. Crown A, Lightman S. Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin En-docrinol (Oxf). 2005; 63:483-492.
147. Grossman AB, Johannsson G, Quinkler M., Zelissen P. Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Europ J of Endocr. 2013; 169:R165-R175.
148. Karssen AM, Meijer OC, Berry A, Sanjuan Piñol R, de Kloet ER. Low doses of dexamethasone can produce a hypocorticosteroid state in the brain. Endocrinology. 2005; 146:5587-5595.
149. Raubenheimer PJ, Young EA, Andrew R, Seckl JR. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback. Clin Endocrinol (Oxf). 2006; 65:22-26.
150. Born J, de Kloet ER, Wenz H, Fehm HL. Gluco-and mineralocor-ticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol. 1991; 260:183-188.
151. Liston C, Gan WB. Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo. Proc Natl Acad Sci USA. 2011; 108:16074-16079.
152. Liston C, Cichon JM, Jeanneteau F, Jia Z, Chao M.V., Gan WB. Circadian glucocorticoid oscillations promote learning-dependent synapse formation and maintenance. Nat Neurosci. 2013; 16:698-705.
153. de Kloet ER, Oitzl MS, Joëls M. Stress and cognition: are cortico-steroids good or bad guys? Trends Neurosci. 1999; 22:422-426.
154. Joëls M, Pu Z, Wiegert O, Oitzl M.S., Krugers HJ. Learning under stress: How does it work? Trends Cogn Sci. 2006; 10:152-158.
155. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nature Rev Neurosci. 2009; 10:434-445.
156. van Ast VA, Cornelisse S, Meeter M, Joëls M, Kindt M. Time-dependent effects of cortisol on the contextualization of emotional memories. Biol Psychiatry. 2013; 74:809-816.
157. de Quervain DJ, Roozendaal B, McGaugh JL. Stress and gluco-corticoids impair retrieval of long-term spatial memory. Nature. 1998; 394:787-790.
158. Kaouane N, Porte Y, Vallée M, et al. Glucocorticoids can induce PTSD-like memory impairments in mice. Science. 2012; 335: 1510-1513.
159. Zhou M, Bakker EH, Velzing EH, et al. Both mineralocorticoid and glucocorticoid receptors regulate emotional memory in mice. Neurobiol Learn Mem. 2010; 94:530-537.
160. Zhou M, Kindt M, Joëls M, Krugers HJ. Blocking mineralocorticoid receptors prior to retrieval reduces contextual fear memory in mice. PLoS One. 2011; 6:e26220.
161. Zohar J. Juven-Wetzler A, Sonnino R, Cwikel-Hamzany S, Balaban E, Cohen H. High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interval between clinical and animal studies. Eur Neuropsychopharm. 2011; 21:796-809.
162. Asagami T, Belanoff JK, Azuma J, Blasey CM, Clark R.D., Tsao PS. Selective glucocorticoid receptor (GR-II) antagonist reduces body weight gain in mice. J Nutr Metab. 2011; 235389.
163. Blasey CM, Block TS, Belanoff JK, Roe RL. Efficacy and safety of mifepristone for the treatment of psychotic depression. J Clin Psy-chopharmacol. 2011; 31:436-440.
164. Revsin Y, Rekers NV, Louwe MC, et al. Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuro-psychopharmacology. 2009; 34:747-758.
165. Grossmann C, Scholz T, Rochel M, et al. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol. 2004; 151:397-406.
166. Souza RR, Dal Bó S, de Kloet ER, Oitzl MS, Carobrez AP. Paradoxical mineralocorticoid receptor-mediated effect in fear memory encoding and expression of rats submitted to an olfactory fear conditioning task. Neuropharmacology. 2014; 79:201-211.
167. Lembke A, Gomez R, Tenakoon L, et al. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psy-choneuroendocrinology. 2013; 38:115-121.
168. Groch S, Wilhelm I, Lange T, Born J. Differential contribution of mineralocorticoid and glucocorticoid receptors to memory formation during sleep. Psychoneuroendocrinology. 2013; 38:2961-1972.
169. Wingelfeld K, Kuehl LK, Janke K, et al. Enhanced emotional empathy after mineralocrticoid receptor stimulation in women with borderline personality disorder and healthy women. Neuropsy-chopharmacology. 2014; 39:1799-1804.
170. Otte C, Hinkelman K, Moritz S, et al. Modulation of the mineralocorticoid receptor as add-on treatment in depression, a randomized double-blind, placebo controlled proff-of-concept study. J Psych Res. 2010; 44:339-346.
171. DeRijk RH, Wüst S, Meijer OC, et al. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab. 2006; 91:5083-5089.
172. Klok MD, Giltay EJ, Van der Does AJ, et al. A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Transl Psychiatry. 2011; 1:e62.
173. van Leeuwen N, Caprio M, Blaya C, et al. The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels. Hypertension. 2010; 56:995-1002.
174. Ackermann S, Heck A, Rasch B, Papassotiropoulos A., de Quervain DJ. The BclI polymorphism of the glucocorticoid receptor gene is associated with emotional memory performance in healthy individuals. Psychoneuroendocrinology. 2013; 38:1203-1207.
175. Selye H. The Stress of Life (rev. edn.). New York, NY: McGraw-Hill; 1976.
176. de Kloet ER, Van Acker SA, Sibug RM, et al. Brain mineralocor-ticoid receptors and centrally regulated functions. Kidney Int. 2000; 57:1329-1336.
177. Joëls M, Karst H, DeRijk R, de Kloet ER. The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 2008; 31:1-7.
178. McEwen BS, Gianaros PJ. Stress- and Allostasis-induced brain plasticity. Annu Rev Med. 2011; 62:431-445.
179. McEwen BS, Wingfield JC. What is in a name? Integrating homeo-stasis, allostasis and stress. Horm Behav. 2010; 57:105-111.
180. van Praag HM, de Kloet ER, van Os J. Stress, the Brain and Depression. Cambridge, UK: Cambridge University Press; 2004.
181. Mehta D, Klengel T, Conneely K.N., et al. Childhood maltreatment is associated with distinct genomic and epigenetic profiles in post-traumatic stress disorder. Proc Natl Acad Sci USA. 2013; 110: 8302-8307.
182. Holsboer F, Ising M. Stress hormone regulation: biologicalrole and translation into therapy. Annu Rev Psychol. 2010; 61:81-109, C1-C11.
183. Schumann G, Binder EB, Holte A, et al. Stratified medicine for mental disorders. Eur Neuropsychopharmacol. 2013; 24:5-50.
184. Selye H. A syndrome produced by diverse nocuous agents. Nature. 1936; 138:132.
185. Cannon WB. The Wisdom of the Body. Revised and Enlarged Edition. New York, NY: WW Norton; 1993.
186. McEwen BS. Stress, definitions and concepts of. In: Fink G, ed. Encyclopedia of Stress. Vol 3. San Diego, CA: Academic Press; 2000:508-509.
187. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioural homeostasis. JAMA. 1992; 267:1244-1252.
188. Romero LM, Dickens MJ, Cyr NE. The Reactive Scope Model - a new model integrating homeostasis, allostasis, and stress. Horm Behav. 2009; 55:375-389.
189. Koolhaas JM, Bartolomucci A, Buwalda B, et al. Stress revisited: a critical evaluation of the stress concept. Neurosci Biobehav Rev. 2011; 35:1291-1301.
190. Lazarus, R.S. Emotions and interpersonal relationships: toward a person-centered conceptualization of emotions and coping. J Pers. 2006; 74:9-46.
191. Pruessner JC, Baldwin MW, Dedovic K, et al. Self-esteem, locus of control, hippocampal volume, and cortisol regulation in young and old adulthood. Neuroimage. 2005; 28:815-826.
192. Day TA. Defining stress as a prelude to mapping its neurocircuitry: no help from allostasis. Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29:1195-1200.
193. Raisman G. An urge to explain the incomprehensible: Geoffrey Harris and the discovery of the neural control of the pituitary gland. Annu Rev Neurosci. 1997; 20:533-566.
194. de Wied D. The neuropeptide story. Geoffrey Harris Lecture, Budapest, Hungary, July 1994. Front Neuroendocrinol. 1997; 18: 101-113.
195. Wade N. The Nobel Duel. New York, NY: Doubleday; 1981.
196. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science. 1981; 213:1394-1397.
197. Bittencourt JC. The tale of a person and a peptide: Wylie W. Vale Jr. and the role of corticotropin-releasing factor in the stress response. J Chem Neuroanat. 2013; 54:1-4.
198. Levine S. Developmental determinants of sensitivity and resistance to stress. Psychoneuroendocrinology. 2005; 30:939-946.
199. Karssen AM, Meijer OC, van der Sandt IC, et al. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of cor-ticosterone to mouse and human brain. Endocrinology. 2001; 142: 2686-2694.
200. Groeneweg FL, Karst H, de Kloet ER, Joëls M. Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol. 2011; 209:153-167.